Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026)
Krystal Biotech (KRYS) reported Exchange Rate Effect of -$1.3 million for Q1 2026, down 878.36% on a YoY basis from $171000.0 in Q1 2025, and down 108.95% sequentially from -$637000.0 in Q4 2025.
Krystal Biotech (KRYS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 5 years of Exchange Rate Effect data on file, last reported at -$1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 878.36% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (down 156.54% YoY), and the FY2025 full-year result was $286000.0, up 162.45% from the prior year.
- Exchange Rate Effect declined to -$1.3 million in Q1 2026, from -$637000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q2 2025 to a low of -$1.3 million in Q1 2026.
- A 5-year average of -$121428.6 and a median of -$38500.0 in 2022 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 2283.33% in 2024, while the deepest fall reached 4312.5% in 2024.
- Tracing KRYS's Exchange Rate Effect over 5 years: stood at -$41000.0 in 2022, then sank by 241.46% to -$140000.0 in 2023, then slumped by 324.29% to -$594000.0 in 2024, then decreased by 7.24% to -$637000.0 in 2025, then slumped by 108.95% to -$1.3 million in 2026.
- Business Quant data shows KRYS's Exchange Rate Effect at -$1.3 million in Q1 2026, -$637000.0 in Q4 2025, and -$307000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | -1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33 Mn |
| Mar 31, 2026 | -1.33 Mn |
| Dec 31, 2025 | -637,000.00 |
| Dec 31, 2025 | -637,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Sep 30, 2025 | -307,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 171,000.00 |
| Mar 31, 2025 | 171,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Dec 31, 2024 | -594,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -337,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Mar 31, 2024 | 187,000.00 |
| Dec 31, 2023 | -140,000.00 |
| Dec 31, 2023 | -140,000.00 |